Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

DNA Ginkgo Bioworks Holdings, Inc.

This is a development tutorial for eBPF based on CO-RE (Compile Once, Run Everywhere). It provides practical eBPF development practices from beginner to advanced, including basic concepts, code ...

shiroa serve --font-path ./assets/typst-fonts/ --font-path ./assets/fonts/ -w ../src/ ...